Home Up
Co-brand
Partnerships





| |
9/13/99 Bio-Technology General (BTGC)
Points to watch: BTGC has
outperformed the SP500 since early July, and its recent out performance is
likely to continue. The stock tested important resistance at 11.06,
the 50% retracement of its 2/16/97-8/30/98 intraweek last week, before
closing the week at 10.81. Long term technical indicators continue
to support higher prices, with weekly OBV, RSI, and stochastics all moving
higher. A buy signal would be given on a move above the August 22nd
high of 11.38. Resistance is at 11-11.38, 12.75, 13.68 on the
upside, and support is at 9.5 on the downside.
|

DISCLAIMER
|